These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8052486)

  • 1. Enhanced expression of the multidrug resistance gene in vindesine-resistant human esophageal cancer cells.
    Saito T; Hikita M; Kohno K; Tanimura H; Miyahara M; Kobayashi M
    Oncology; 1994; 51(5):440-5. PubMed ID: 8052486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma.
    Obara K; Ghazizadeh M; Shimizu H; Arai R; Tenjin T; Suzuki S; Moriyama Y; Kawanami O
    Int J Oncol; 2002 Feb; 20(2):255-60. PubMed ID: 11788885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms.
    Saito T; Hikita M; Kohno K; Sato S; Takano H; Kobayashi M
    Cancer; 1992 Nov; 70(10):2402-9. PubMed ID: 1358426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids].
    Kubota R; Kubota K; Yamada S
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2163-7. PubMed ID: 1444481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine-resistant human cancer KB cell line and increased expression of multidrug-resistance gene.
    Kohno K; Kikuchi J; Sato S; Takano H; Saburi Y; Asoh K; Kuwano M
    Jpn J Cancer Res; 1988 Nov; 79(11):1238-46. PubMed ID: 2906349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of a vindesine-resistant human small-cell lung cancer cell line.
    Ohta S; Nishio K; Kubo S; Nishio M; Ohmori T; Takahashi T; Saijo N
    Br J Cancer; 1993 Jul; 68(1):74-9. PubMed ID: 8391305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and expression of a multidrug resistance gene in human glioma cell lines.
    Matsumoto T; Tani E; Kaba K; Kochi N; Shindo H; Yamamoto Y; Sakamoto H; Furuyama J
    J Neurosurg; 1990 Jan; 72(1):96-101. PubMed ID: 2294193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells.
    Lemontt JF; Azzaria M; Gros P
    Cancer Res; 1988 Nov; 48(22):6348-53. PubMed ID: 3180053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of tumor cell lines from a patient with head and neck cancer and their different sensitivities to anti-cancer agents.
    Komiyama S; Matsui K; Kudoh S; Nogae I; Kuratomi Y; Saburi Y; Asoh K; Kohno K; Kuwano M
    Cancer; 1989 Feb; 63(4):675-81. PubMed ID: 2914273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
    Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
    Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
    Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
    Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells.
    Nishio K; Nakamura T; Koh Y; Kanzawa F; Tamura T; Saijo N
    Cancer; 2001 Apr; 91(8):1494-9. PubMed ID: 11301397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes amplified and overexpressed in human multidrug-resistant cell lines.
    Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
    Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
    Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of vincristine and actinomycin D by a new synthetic imidazole anti-tumor agent YM534 active against human cancer cells and multidrug-resistant cells.
    Sato S; Watanabe Y; Okamura K; Hamanaka R; Mori T; Kohno K; Kuwano M
    Anticancer Drug Des; 1989 Aug; 4(2):125-35. PubMed ID: 2803461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
    Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.